The effects of salbutamol on epithelial ion channels depend on the etiology of acute respiratory distress syndrome but not the route of administration

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Uhlig, Christopher ^a,b   Silva, Pedro L ^a   Ornellas, Débora ^a   Santos, Raquel S ^a   Miranda, Paulo J ^a   Spieth, Peter M ^b   Kiss, Thomas ^b   Kasper, Michael ^c   Wiedemann, Bärbel ^c   Koch, Thea ^b   Morales, Marcelo M ^a   Pelosi, Paolo ^d   De Abreu, Marcelo G ^b   Rocco, Patricia R M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Acute respiratory distress syndrome; Alveolar epithelial cells; Edema; Elastance; Epithelial sodium channel; Salbutamol

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AQUAPORIN; AQUAPORIN 1; AQUAPORIN 3; EPITHELIAL SODIUM CHANNEL; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; ION CHANNEL; SALBUTAMOL; SODIUM CHLORIDE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTERIAL PH; ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; EXPERIMENTAL STUDY; GENE EXPRESSION; HEART RATE; HISTOLOGY; LUNG HEMODYNAMICS; LUNG INJURY; LUNG MECHANICS; MALE; MOLECULAR BIOLOGY; NONHUMAN; PRESSURE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RAT; TIDAL VOLUME; ANIMAL; BIOSYNTHESIS; INTRASPINAL DRUG ADMINISTRATION; INTRAVENOUS ADMINISTRATION; METABOLISM; RANDOMIZATION; RESPIRATORY TRACT MUCOSA; TREATMENT OUTCOME; WISTAR RAT;

ADMINISTRATION, INTRAVENOUS; ALBUTEROL; ANIMALS; INJECTIONS, SPINAL; ION CHANNELS; MALE; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RATS; RATS, WISTAR; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY MUCOSA; TREATMENT OUTCOME;

EID: 84900863778     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-15-56     Document Type: Article

References (40)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000, 342(18):1334-1349. 10.1056/NEJM200005043421806, 10793167.
2. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 163(6):1376-1383. 10.1164/ajrccm.163.6.2004035, 11371404.
3. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990, 142(6 Pt 1):1250-1257.
4. Hollenhorst MI, Richter K, Fronius M. Ion transport by pulmonary epithelia. J Biomed Biotechnol 2011, 2011:174306. 3205707, 22131798.
5. Herrero R, Tanino M, Smith LS, Kajikawa O, Wong VA, Mongovin S, Matute-Bello G, Martin TR. The Fas/FasL pathway impairs alveolar fluid clearance in mouse lungs. Am J Physiol Lung Cell Mol Physiol 2013, 305(5):L377-L388. 10.1152/ajplung.00271.2012, 23812636.
6. Basran GS, Hardy JG, Woo SP, Ramasubramanian R, Byrne AJ. Beta-2-adrenoceptor agonists as inhibitors of lung vascular permeability to radiolabelled transferrin in the adult respiratory distress syndrome in man. Eur J Nucl Med 1986, 12(8):381-384.
7. Sakuma T, Suzuki S, Usuda K, Handa M, Okaniwa G, Nakada T, Fujimura S, Matthay MA. Preservation of alveolar epithelial fluid transport mechanisms in rewarmed human lung after severe hypothermia. J Appl Physiol 1996, 80(5):1681-1686.
8. Sakuma T, Folkesson HG, Suzuki S, Okaniwa G, Fujimura S, Matthay MA. Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am J Respir Crit Care Med 1997, 155(2):506-512. 10.1164/ajrccm.155.2.9032186, 9032186.
9. Perkins GD, McAuley DF, Richter A, Thickett DR, Gao F. Bench-to-bedside review: beta2-Agonists and the acute respiratory distress syndrome. Crit Care 2004, 8(1):25-32. 10.1186/cc2417, 420065, 14975042.
10. Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM, van der Zee JS, Bresser P, van der Poll T. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005, 172(7):878-884. 10.1164/rccm.200503-451OC, 15994467.
11. Bosmann M, Grailer JJ, Zhu K, Matthay MA, Sarma JV, Zetoune FS, Ward PA. Anti-inflammatory effects of beta2 adrenergic receptor agonists in experimental acute lung injury. FASEB J 2012, 26(5):2137-2144. 10.1096/fj.11-201640, 3336792, 22318967.
12. McAuley DF, Frank JA, Fang X, Matthay MA. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004, 32(7):1470-1476. 10.1097/01.CCM.0000129489.34416.0E, 15241090.
13. Frank JA, Wang Y, Osorio O, Matthay MA. Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats. J Appl Physiol 2000, 89(4):1255-1265.
14. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006, 173(3):281-287. 10.1164/rccm.200508-1302OC, 16254268.
15. Gao Smith F, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE. BALTI-2 study investigators: Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012, 379(9812):229-235. 10.1016/S0140-6736(11)61623-1, 3266479, 22166903.
16. Heart N, Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, Hite D, Holets S, Kallet RH, Liu KD, MacIntyre N, Moss M, Schoenfeld D, Steingrub J, Thompson BT, . Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011, 184(5):561-568. 3175548, 21562125, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network.
17. Menezes SL, Bozza PT, Neto HC, Laranjeira AP, Negri EM, Capelozzi VL, Zin WA, Rocco PR. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J Appl Physiol 2005, 98(5):1777-1783. 10.1152/japplphysiol.01182.2004, 15649870.
18. Riva DR, Oliveira MB, Rzezinski AF, Rangel G, Capelozzi VL, Zin WA, Morales MM, Pelosi P, Rocco PR. Recruitment maneuver in pulmonary and extrapulmonary experimental acute lung injury. Crit Care Med 2008, 36(6):1900-1908. 10.1097/CCM.0b013e3181760e5d, 18496360.
19. Santos FB, Nagato LK, Boechem NM, Negri EM, Guimaraes A, Capelozzi VL, Faffe DS, Zin WA, Rocco PR. Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury. J Appl Physiol 2006, 100(1):98-106. 10.1152/japplphysiol.00395.2005, 16109834.
20. Peterson BT, Brooks JA, Zack AG. Use of microwave oven for determination of postmortem water volume of lungs. J Appl Physiol 1982, 52(6):1661-1663.
21. Spieth PM, Carvalho AR, Guldner A, Kasper M, Schubert R, Carvalho NC, Beda A, Dassow C, Uhlig S, Koch T, Pelosi P. Pressure support improves oxygenation and lung protection compared to pressure-controlled ventilation and is further improved by random variation of pressure support. Crit Care Med 2011, 39(4):746-755. 10.1097/CCM.0b013e318206bda6, 21263322.
22. Martin TR, Matute-Bello G. Experimental models and emerging hypotheses for acute lung injury. Crit Care Clin 2011, 27(3):735-752. 10.1016/j.ccc.2011.05.013, 3159414, 21742226.
23. Bennett JA, Smyth ET, Pavord ID, Wilding PJ, Tattersfield AE. Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax 1994, 49(8):771-774. 10.1136/thx.49.8.771, 475121, 8091321.
24. Marunaka Y, Niisato N, O'Brodovich H, Eaton DC. Regulation of an amiloride-sensitive Na+-permeable channel by a beta2-adrenergic agonist, cytosolic Ca2+ and Cl- in fetal rat alveolar epithelium. J Physiol 1999, 515(Pt 3):669-683. 2269183, 10066896.
25. Chen XJ, Eaton DC, Jain L. Beta-adrenergic regulation of amiloride-sensitive lung sodium channels. Am J Physiol Lung Cell Mol Physiol 2002, 282(4):L609-L620.
26. Pesce L, Comellas A, Sznajder JI. Beta-adrenergic agonists regulate Na-K-ATPase via p70S6k. Am J Physiol Lung Cell Mol Physiol 2003, 285(4):L802-L807.
27. Rocco PR, Dos Santos C, Pelosi P. Lung parenchyma remodeling in acute respiratory distress syndrome. Minerva Anestesiol 2009, 75(12):730-740.
28. Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997, 390(6655):88-91. 10.1038/36362, 9363896.
29. Mutlu GM, Factor P. Alveolar epithelial beta2-adrenergic receptors. Am J Respir Cell Mol Biol 2008, 38(2):127-134. 10.1165/rcmb.2007-0198TR, 2214676, 17709598.
30. He X, Hu JL, Li J, Zhao L, Zhang Y, Zeng YJ, Dai SS, He FT. A feedback loop in PPARgamma-adenosine A2A receptor signaling inhibits inflammation and attenuates lung damages in a mouse model of LPS-induced acute lung injury. Cell Signal 2013, 25(9):1913-1923. 10.1016/j.cellsig.2013.05.024, 23712033.
31. Brant KA, Fabisiak JP. Role of hypoxia-inducible factor 1, alpha subunit and cAMP-response element binding protein 1 in synergistic release of interleukin 8 by prostaglandin E2 and nickel in lung fibroblasts. Am J Respir Cell Mol Biol 2013, 49(1):105-113. 10.1165/rcmb.2012-0297OC, 23526216.
32. Bassford CR, Thickett DR, Perkins GD. The rise and fall of beta-agonists in the treatment of ARDS. Crit Care 2012, 16(2):208. 10.1186/cc11221, 3681353, 22429604.
33. Dincer HE, Gangopadhyay N, Wang R, Uhal BD. Norepinephrine induces alveolar epithelial apoptosis mediated by alpha-, beta-, and angiotensin receptor activation. Am J Physiol Lung Cell Mol Physiol 2001, 281(3):L624-L630.
34. Minnear FL, DeMichele MA, Moon DG, Rieder CL, Fenton JW. Isoproterenol reduces thrombin-induced pulmonary endothelial permeability in vitro. Am J Physiol 1989, 257(5 Pt 2):H1613-H1623.
35. Perkins GD, Gao F, Thickett DR. In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury. Thorax 2008, 63(3):215-220. 10.1136/thx.2007.080382, 17951278.
36. Downs CA, Kriener LH, Yu L, Eaton DC, Jain L, Helms MN. beta-Adrenergic agonists differentially regulate highly selective and nonselective epithelial sodium channels to promote alveolar fluid clearance in vivo. Am J Physiol Lung Cell Mol Physiol 2012, 302(11):L1167-L1178. 10.1152/ajplung.00038.2012, 3379040, 22505670.
37. Tan KS, Nackley AG, Satterfield K, Maixner W, Diatchenko L, Flood PM. Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms. Cell Signal 2007, 19(2):251-260. 10.1016/j.cellsig.2006.06.007, 16996249.
38. Pesenti A, Pelosi P, Rossi N, Aprigliano M, Brazzi L, Fumagalli R. Respiratory mechanics and bronchodilator responsiveness in patients with the adult respiratory distress syndrome. Crit Care Med 1993, 21(1):78-83. 10.1097/00003246-199301000-00016, 8420734.
39. Morina P, Herrera M, Venegas J, Mora D, Rodriguez M, Pino E. Effects of nebulized salbutamol on respiratory mechanics in adult respiratory distress syndrome. Intensive Care Med 1997, 23(1):58-64. 10.1007/s001340050291, 9037641.
40. Curley G, Hayes M, Laffey JG. Can 'permissive' hypercapnia modulate the severity of sepsis-induced ALI/ARDS?. Crit Care 2011, 15(2):212. 10.1186/cc9994, 3219408, 21457509.